A new Chief Executive Officer with decades of pharmaceutical industry experience is taking the helm at Australian medical cannabis firm Cann Group (ASX: CAN). The company announced on Tuesday Peter Koetsier will step into the CEO role next week to replace Peter Crock, who spent nearly seven years in the position. Mr. Koetsier has 30 … Continue reading Australia’s Cann Group Scores New CEO